erythrosine has been researched along with trans-sodium crocetinate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H; Imai, S; Nakanishi, T; Shimazawa, M; Tsuruma, K; Umigai, N; Yamauchi, M | 1 |
| Clarke, R; Lee, KS; Schretter, C; Wang, Y | 1 |
2 other study(ies) available for erythrosine and trans-sodium crocetinate
| Article | Year |
|---|---|
Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity.
Topics: Administration, Oral; Animals; Carotenoids; Caspase Inhibitors; Caspases; Cell Death; Cell Line; Chromans; Endoplasmic Reticulum; Enzyme Activation; Enzyme Inhibitors; Fluoresceins; Gene Expression Regulation; Humans; Hydrogen Peroxide; Intracellular Space; Light; Male; Membrane Potential, Mitochondrial; Mice; Oxidation-Reduction; Oxidative Stress; Photoreceptor Cells, Vertebrate; Rats; Retinal Degeneration; Retinal Ganglion Cells; Tunicamycin; Vitamin A; Xanthenes | 2011 |
Perihematomal Cellular Injury Is Reduced by Trans-sodium Crocetinate in a Model of Intracerebral Hemorrhage.
Topics: Animals; Carotenoids; Caudate Nucleus; Cell Count; Cerebral Hemorrhage; Collagenases; Drug Evaluation, Preclinical; Fluoresceins; Fluorescent Dyes; Hematoma; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Putamen; Rabbits; Rats; Rats, Sprague-Dawley; Vitamin A | 2015 |